$ETON

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (1y)
Win rate (1y)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$ETONSEC Form 4bearish
Sold 100,000 @ $60.88 avg · $6,087,773 · 2026-08-19

Form 4: BRYNJELSEN SEAN sold ETON

BRYNJELSEN SEAN (President & CEO at Eton Pharmaceuticals, Inc.) reported an open-market sale of 100,000 shares of ETON at an average $60.88, roughly $6,087,773, in a Form 4 filed 2026-08-20.

View filing on SEC.gov →

End of results.